TREATMENT OF PRIMARY OSTEO-SARCOMA WITH INTRA-ARTERIAL AND INTRAVENOUS HIGH-DOSE METHOTREXATE

被引：39

作者：

JAFFE, N

PRUDICH, J

KNAPP, J

WANG, YM

BOWMAN, R

CANGIR, A

AYALA, A

CHUANG, V

WALLACE, S

机构：

[1] UNIV TEXAS, MD ANDERSON HOSP & TUMOR INST,CTR CANC, TEXAS MED CTR,DEPT PATHOL, HOUSTON, TX 77030 USA

[2] UNIV TEXAS, MD ANDERSON HOSP & TUMOR INST,CTR CANC, TEXAS MED CTR,DEPT RADIOL, HOUSTON, TX 77030 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1983年 / 1卷 / 07期

关键词：

D O I：

10.1200/JCO.1983.1.7.428

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：428 / 431

页数：4

共 18 条

[1]

COHEN HJ, 1978, CANCER CHEMOTH PHARM, V1, P61

[2] ADJUVANT CHEMOTHERAPY OF OSTEOGENIC-SARCOMA - PROGRESS AND PERSPECTIVES [J].

FREI, E ;

JAFFE, N ;

GERO, M ;

SKIPPER, H ;

WATTS, H .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1978, 60 (01) :3-10

[3]

JAFFE N, 1972, CANCER-AM CANCER SOC, V30, P1627, DOI 10.1002/1097-0142(197212)30:6<1627::AID-CNCR2820300631>3.0.CO

[4]

2-H

[5]

JAFFE N, 1978, CANCER TREAT REP, V62, P217

[6]

Jaffe N, 1981, Natl Cancer Inst Monogr, P201

[7]

JAFFE N, 1977, CANCER, V39, P45, DOI 10.1002/1097-0142(197701)39:1<45::AID-CNCR2820390109>3.0.CO

[8]

2-T

[9]

JAFFE N, 1981, CANCER TREAT REP, V65, P99

[10]

KIM J, 1977, P AM ASSOC CANC RES, V18, P123

← 1 2 →